“As scientists for Cancer Research UK, the Therapeutic Discovery Labs based in Cambridge made the decision to continue to work in the lab during the pandemic.
"Initially for many of us this felt like a difficult decision, one that many of us had no idea how we were going to make work. Many of our friends and family (excepting key workers) are working from home or furloughed, and many of our fellow scientists have moved into the crucial research around COVID or into helping out with the testing effort.
"Initially it felt strange to keep our focus on cancer.
“With challenges from getting enough of our normal consumables, problems with supply chains and deliveries, to who is teaching the kids today, the challenges continue to change, mutate and grow as this crisis continues to batter the world. My colleagues, always inventive problem solvers, have consistently surprised me with their resilience and ingenuity to find new ways to overcome these obstacles.
“Having worked alongside fantastic scientists for years it is not the ingenuity that has surprised me the most, but the way we have pulled together to work as a team. The virus has left us with staff shortages in areas such as lab support, this has meant that our head of chemistry, now known as, ‘mystery house elf’ has been accepting deliveries and helping to re-stock the store room.
"We have people working from home supporting those in the lab any way that they can, organising shipments and checking that deliveries can be made. We have colleagues listening, caring and sharing their struggles, which are different for each of us, and supporting each other in the best way possible.
"Whilst coronavirus may be at the forefront of all of our minds, cancer is still killing as many people as it was, and our job is still a very important one. I feel very lucky to work in such a dedicated team of brilliant and supportive people.”
Joanna Brookfield is a researcher at Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), based at the Babraham Research Campus, Cambridge, and a member of our Onco-Innovation Programme. CRUK-TDL is the in-house CRUK drug discovery unit with a principal focus on establishing and prosecuting biologically-themed multi-project alliances with industry.